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ABSTRACT Serine transhydroxymethylase (5,10-methy-
lenetetrahydrofolate: glycine hydroxymethyl transferase, EC
2.1.2.1) purified 200-fold from pig kidneys showed cooperative
interactions with tetrahydrofolate with a Hill coefficient (n
value) of 3.9 and a substrate concentration at 50% of maximum
velocity, the So.s value, of 0.5 mM. The enzyme in mouse liver
and kidney homogenates also showed cooperative interactions
with tetrahydrofolate. However, the enzyme obtained from
L1210 solid tumors of mice, and from livers and kidneys of mice
inoculated with L1210 cells exhibited hyperbolic saturation
kinetics and gave a Michaelis constant, K., value of 0.5 mM for
tetrahydrofolate. The interaction of serine with the enzyme
from pig kidney, from tissues of normal or tumor-bearing mice
or from L1210 tumors was hyperbolic with a Km of 0.9 mM. The
specific activities of the enzyme in the L1210 tumor and in
mouse liver were 10-fold higher than in pig or mouse kidney.
There was no significant change in the levels of the enzyme in
mouse liver and kidney on inoculation with L1210 cells.
These results suggest that a tumor can bring about biochem-
ical changes in tissues that are distal to the tumor.
Serine transhydroxymethylase (EC 2.1.2.1) catalyzes the
transfer of the hydroxymethyl group from serine to 5,6,7,8-
tetrahydrofolate to yield 5,10-methylenetetrahydrofolate and
glycine as products of the reaction. 5,10-Methylenetetrahy-
drofolate is a common precursor for: the biosynthesis of the
methyl group of methionine (1); thymidylate (2); purine carbon
atoms 2 and 8 (3); the formyl group of formylmethionyl-tRNA
(4); and the hydroxymethyl group of hydroxymethyl-dCMP
and hydroxymethyl-dUMP (5, 6). Serine transhydroxy-
methylase isolated from a number of mammalian sources (7,
8) has a molecular weight of 215,000, is polymeric (9), and binds
4 moles of pyridoxal 5'-phosphate (pyridoxal-P) per mole of
enzyme (10). This enzyme has been purified from bacteria (11,
12) and in Escherichia coli enzyme synthesis is repressed by
methionine (13). Most often in the study of the mechanism of
this enzyme from mammalian systems (14) glycine and form-
aldehyde or threonine are used as substrates. In this commu-
nication, we report the allosteric interactions of tetrahydrofolate
with serine transhydroxymethylase purified from pig kidney,
and in homogenates of mouse liver and kidney; and the absence
of these cooperative effects in the enzyme obtained from L1210
solid tumors, or from livers and kidneys of mice containing these
tumors.
MATERIALS AND METHODS
Pyridoxal 5-phosphate, ethylenediaminetetraacetate (EDTA),
Abbreviations: pyridoxal-P, pyridoxal 5'-phosphate; CM-Sephadex,
carboxymethyl-Sephadex; dimedone, 5,5-dimethyl-1,3-cyclohex-
anedione.
* To whom request for reprints are to be sent.
t On sabbatical leave from the Department of Biochemistry, Indian
Institute of Science, Bangalore-560012, India.
dithiothreitol, 2-mercaptoethanol, and 5,5-dimethyl-1,3-cy-
clohexanedione (dimedone) were obtained from Sigma
Chemical Co; carboxymethyl- (CM)-Sephadex C-50, from
Pharmacia Fine Chemicals Inc.; [3_14C]serine from New En-
gland Nuclear Corp.; and pig kidneys, from the local slaught-
erhouse; Tetrahydrofolate was prepared by the catalytic hy-
drogenation of folic acid by the method of O'Dell et al., as
modified by Hatefi et al. (15).
L1210 solid tumors were induced by injecting an L1210
culture subcutaneously into the flanks of mice (strain BDFI).
After 7 days the solid tumors were dissected out and frozen
immediately in liquid nitrogen. They were kept frozen at -700
until use.
Assay for Serine Transhydroxymethylase. The reaction
mixture (0.55 ml) contained: 301Amol of potassium phosphate
buffer, pH 7.4; 0.1 ,tmol of pyridoxal-P; 1 Mmol of tetrahy-
drofolate dissolved in 0.3 M potassium phosphate buffer at pH
7.4 which also contained 1 mM dithiothreitol; and an appro-
priate amount of the enzyme. The mixture was initially incu-
bated for 5 min at 370 and then 0.2 1mol of L-[3-'4C]serine (3
X 106 cpm/gtmol) was added and the incubation was continued
for an additional 15 min at 370. The reaction was stopped by
adding 0.3 ml of dimedone (0.4 M in 50% ethanol) and by
placing the tubes in a boiling-water bath for 5 min. The tubes
were cooled for 5 min in ice, and the formaldehyde-dimedone
adduct was extracted into 3 ml of toluene by vigorous shaking
on a Vortex mixer for 30 sec. The tubes were then centrifuged
for 2 min and 1.0 ml of the toluene layer was mixed with
Aquasol (10 ml) and radioactivity was measured in a Tri-Carb
liquid scintillation spectrometer. This procedure is essentially
similar to that described by Taylor and Weissbach (16).
One unit of enzyme activity was defined as the amount of
enzyme required to produce 1 pumol of formaldehyde per hr
at 370 and at pH 7.4.
Purification of Serine Transhydroxymethylase from Pig
Kidney. Frozen pig kidneys (1.2 kg) were thawed, cut into
cubes of 1 inch (2.5 cm) and homogenized with 3.5 liters of 0.03
M potassium phosphate buffer (pH 7.4) in a Waring Blendor
for 1 min. To the crude extract (Table 1) obtained on centrif-
ugation at 35,000 X g for 30 min, solid ammonium sulfate (300
g/2.2 liters) was added to achieve 0.25 saturation. The pre-
cipitate obtained on centrifugation at 35,000 X g was discarded.
Solid ammonium sulfate (340 g/2.3 liters) was added to the
supernatant solution to raise the saturation to 0.5. The precip-
itate was collected by centrifugation at 35,000 X g for 15 min,
dissolved in 0.05 M phosphate buffer (pH 7.4) containing 10
,gM pyridoxal-P, 20mM EDTA, and 1 mM 2-mercaptoethanol,
and dialyzed for 24 hr against 4 liters of the same buffer. The
clear supernatant solution (ammonium sulfate fraction, Table
1) was layered on a CM-Sephadex C-50 column (3 X 32 cm)
previously equilibrated with 0.05 M phosphate buffer (pH 7.4)
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Table 1. Purification of serine transhydroxymethylase
from pig kidney
Specific
Total activity, Fold
activity, units/mg purifi- Recovery,
Fraction units* of protein cation %
Crude extract 633 0.012 1 100
Ammonium
sulfate
precipitate 500 0.060 5 94
CM-Sephadex
eluate 561 2.4 200 88
Purification of serine transhydroxymethylase from pig kidney.
The following pig kidney preparations-the crude extract (3.8 mg
of protein), the ammonium sulfate precipitate (3.4 mg of protein),
or the CM-Sephadex eluate (200 ,g of protein)-were preincubated
for 5 min at 370 with tetrahydrofolate (1.5 mM). The reaction was
started by the addition of 0.2 umol of L-[3-14C]serine and the en-
zyme was assayed by estimating the formaldehyde formed by the
method of Taylor and Weissbach (16). Protein was determined by
the biuret method (19).
* Micromoles of formaldehyde formed per hr.
containing pyridoxal-P (10 ,M), EDTA (20 mM), and 2-mer-
captoethanol (1 mM). The protein was eluted from the column
with a linear gradient of 0.05-0.5 M phosphate buffer, pH 7.4.
These buffers also contained pyridoxal-P (10MuM), EDTA (20
mM), and 2-mercaptoethanol (1 mM). The fractions containing
serine transhydroxymethylase activity were pooled and used
without any additional processing in these studies. The results
of a representative purification procedure are summarized in
Table 1. This procedure resulted im a 200-fold purification with
an 88% recovery. This preparation was not contaminated with
the following folate-requiring enzymes: methionine synthetase,
5,10-methylenetetrahydrofolate reductase, and 5,10-methy-
lenetetrahydrofolate dehydrogenase.
Preparation of the Enzyme Extract from Mouse Kidney
and Liver, and from L1210 Solid Tumors. The liver and kid-
neys were dissected from both normal and tumor-bearing mice
and homogenized for 1 min in a Waring Blendor with 2 vol-
umes of 0.3 M potassium phosphate buffer (pH 7.4). The su-
pernatant solution obtained on centrifugation at 35,000 X g for
15 min was used as the enzyme source. In the case of the tumors,
50 g of frozen tumor tissue were allowed to thaw at room
temperature and homogenized with 100 ml of 0.3 M potassium
phosphate buffer, pH 7.4, for 1 min in a Waring Blendor. The
supernatant solution obtained upon centrifugation at 35,000
X g provided the tumor serine transhydroxymethylase used in
these studies.
RESULTS
Cooperative Interactions of Tetrahydrofolate with Pig
Kidney Serine Transhydroxymethylase. The enzyme (200 ,g)
was preincubated for 5 min with tetrahydrofolate (0.04-1.0
,Mmol) and assayed for activity. From Fig. 1, which represents
the relationship between the reciprocal of the substrate con-
centration and reciprocal of initial velocity, it is evident that
cooperative effects are present. A sigmoid curve (not shown in
Fig. 1) was obtained when initial velocity was plotted against
tetrahydrofolate concentration. The n value calculated from
the Hill plot (insert Fig. 1) was 3.9. The substrate concentration
at 50% of maximum velocity, the SO.5 value, was 0.5 mM.
The enzyme was treated with urea (6 M) and the urea was
subsequently removed by extensive dialysis. When the
Table 2. Serine transhydroxymethylase activity in L1210
solid tumors, in liver and kidney of normal and
tumor-bearing mice, and in pig kidney
Tissue Specific activity*
Pig kidney 0.012
Normal mice
Liver 0.115
Kidney 0.017
Li 21 0-tumor-bearing mice
Liver 0.123
Kidney 0.017
L1210 solid tumor 0.098
* Micromoles of formaldehyde formed per hr/mg of protein.
renatured enzyme was assayed at the concentrations of te-
trahydrofolate indicated in Fig. 1, a linear Lineweaver-Burk
plot (not shown in the figure) was obtained. The v versus [S]
plots were hyperbolic. The Hill plot gave a Hill coefficient (n
value) of 1. The Km for tetrahydrofolate and V values of the
desensitized enzyme were 1.7 mM and 2.0 Mtmol of formalde-
hyde formed per hr/mg of protein, respectively.
Levels of Serine Transhydroxymethylase in Tissues of Pigs
and Mice, and in L1210 Solid Tumors. It is evident from re-
sults presented in Table 2 that the specific activity in extracts
obtained from the livers of both normal and tumor-bearing
mice was higher than in both pig and mouse kidney. The level
of activity in the L1210 tumors was high and was comparable
to that present in the mouse liver.
Tetrahydrofolate Saturation Curve for Serine Transhy-
droxymethylase from L1210 Tumor. The interaction of te-
trahydrofolate with serine transhydroxymethylase from L1210
tumors is shown in Fig. 2. The enzyme clearly followed hy-
perbolic saturation kinetics, as is evident from the linear double
reciprocal plot. The Hill plot (insert Fig. 2) gave an n value of
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FIG. 1. Lineweaver-Burk plot for the saturation of pig kidney
serine transhydroxymethylase by tetrahydrofolate. The purified
enzyme (200 Mg) was preincubated for 5 min at 370 with the tetrahy-
drofolate concentrations indicated in the figure. The reciprocal of the
tetrahydrofolate concentration was plotted against the reciprocal of
the initial velocity v, i.e., the jimol of formaldehyde formed per hr in
the reaction mixture. The insert (Hill plot) represents the log of the
tetrahydrofolate concentration plotted against the log of v divided
by V the maximum velocity minus v. An n value of 3.9 was calculated
from the slope of the plot.
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FIG. 2. Double reciprocal plots for the interaction of tetrahy-
drofolate with serine transhydroxymethylase from mouse L1210
tumor tissue. An aliquot ofthe supernatant fraction (0.1 ml containing
2.7 mg of protein) of L1210 tumor tissue was preincubated for 5 min
at 370 with the tetrahydrofolate concentrations indicated in the figure
and the enzyme activity was determined. An n value of 1 was calcu-
lated from the slope of the Hill plot (insert).
Saturation by Tetrahydrofolate of Serine Transhydroxy-
methylase from Normal and L1210-Tumor-Bearing Mice.
The saturation by tetrahydrofolate of the enzyme from livers
of normal and tumor-bearing mice is shown in Fig. 3. When
the enzyme obtained from livers of normal mice was analyzed,
the reciprocal plot curved upwards and the Hill plot (insert)
gave an n value of 2.4. In contrast to these observations, serine
transhydroxymethylase from liver of tumor-bearing animals
gave a linear Lineweaver-Burk plot and an n value of 1. The
saturation curves for tetrahydrofolate (v versus [S]) were hy-
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FIG. 3. Double reciprocal plots for the interaction of tetrahy-
drofolate with serine transhydroxymethylase from liver of mice
bearing L1210 tumors and from normal mouse liver. Livers from
normal mice and from mice bearing L1210 tumors were separately
homogenized in 2 vol (wt/vol) of 0.3 M potassium phosphate buffer
at pH 7.4 and centrifuged at 35,000 X g for 15 min. Aliquots of the
supernatant fraction (0.1 ml) containing the enzyme (2.8 mg of protein
the case of the normal mouse liver and 2.6 mg of protein for mouse
liver from tumor-bearing animals) were separately preincubated for
5 min at 370 with the concentrations of tetrahydrofolate indicated
in the figure and assayed for enzyme activity. An n value of 2.4 for the
normal mouse liver enzyme and an n value of 1 for the mouse enzyme
from tumor-bearing animals was calculated from the slope of the Hill
plots.
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FIG. 4. Double reciprocal plot of the interaction of L-serine with
purified pig kidney serine transhydroxymethylase. The purified en-
zyme (130 ug) was preincubated with the various concentrations of
L-[2-14C]serine indicated in the figure and 0.15 mM pyridoxal-P and
assayed in the presence of 1.5mM tetrahydrofolate. Identical results
were obtained with the L1210 tumor and mouse liver enzyme prepa-
rations.
perbolic in the case of the enzyme from livers of tumor-bearing
animals and sigmoid for the enzyme from livers of non-
tumor-bearing animals.
Identical results to those described above were obtained when
kidney tissues from tumor-bearing and control animals were
examined.
Saturation of Pig Kidney, L1210 Tumor, and Mouse Liver
(Obtained from Normal and Tumor-Bearing Mice) Serine
Transhydroxymethylase by L-Serine. When serine concen-
tration was varied at a fixed concentration of tetrahydrofolate
(1.5 mM), classical hyperbolic saturation kinetics (Fig. 4 rep-
resents saturation of the purified pig kidney enzyme) were
observed and gave a Km value of 0.9 mM, a V value of 2.7 umol
of formaldehyde formed per hr/mg of protein, and an n of 1
(Fig. 4).
DISCUSSION
An examination of the pathways for the interconversion of fo-
late coenzymes reveals the central position occupied by 5,10-
methylenetetrahydrofolate (17). A priori one would expect that
enzymes involved in the synthesis and utilization of this key
metabolite would be subject to modulation by effector mole-
cules. Serine transhydroxymethylase catalyzes the formation
of 5,10-methylenetetrahydrofolate from serine and tetrahy-
drofolate. The nonlinear effects of tetrahydrofolate on the
enzyme-glycine complex (14) were interpreted to suggest co-
operative interactions with tetrahydrofolate. Definitive evi-
dence on the nature of these interactions was not presented.
The sigmoid saturation curve with tetrahydrofolate, non-
linear Lineweaver-Burk plot, and an n value of 3.9 strongly
suggested the existence of positive cooperative effects (18) in
the binding of tetrahydrofolate to the purified pig kidney serine
transhydroxymethylase. This conclusion was further supported
by the observation that denaturation by urea and renaturation
by removal of urea resulted in desensitization of the enzyme
to this allosteric interaction. One probable reason for earlier
workers' not observing this phenomenon may have been that
the heat denaturation step to remove contaminating proteins
resulted in the desensitization of the enzyme to cooperative
binding by tetrahydrofolate. The novel observation of coop-
erative interactions involving tetrahydrofolate with this poly-
meric protein suggests a probable regulatory role for this en-
zyme.
The level of the enzyme in L1210 solid tumors was about 10
times higher than in mouse or pig kidney. These elevated values
were similar to those observed in livers of control and tumor-
bearing (L1210) animals.
In contrast to the observation with the pig kidney enzyme,
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the enzyme from L1210 solid tumors differed in that it exhib-
ited Michaelis-Menten kinetics as evidenced by hyperbolic
substrate saturation, linear reciprocal plots, and an n value of
1 (Fig. 2). An additional significant finding was that the enzyme
from the liver and kidneys of normal mice was cooperative (Fig.
3), whereas the enzyme from tumor-bearing animals failed to
show any cooperativity (Fig. 3) in its interactions with te-
trahydrofolate. These results demonstrate that a significant
change in the kinetic behavior of the liver and kidney enzyme
has occurred due to the presence of the tumor. These results
might be attributed to an alteration in enzyme structure re-
sulting in the weakening of subunit interactions; or the pro-
duction of a metabolite, possibly an activator; or the synthesis
of a new enzyme; or the loss of an allosteric binding site.
The alteration in the kinetic properties of an enzyme present
in tissues (liver and kidney) located distal to the site of a tumor
indicates the possibility of the production of a chemical mes-
senger by the tumor, which is transported to and produces
biochemical changes in other tissues of the animal.
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